Search Browse Earnings

DURECT CORP — SlamSEC

DURECT CORP

Pharmaceutical Preparations·CUPERTINO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$2.6M

-81.5% YoY

FY 2024

Adj. EBITDA

-$39.7M

-1530.9% margin

FY 2024

Net Income

-$27.6M

-1066.6% margin

FY 2024

EPS (Diluted)

-$1.20

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$28.4M

FY 2024

Total Debt

$20.6M

FY 2022

Net Cash

$7.8M

FY 2022

Enterprise Value

—

Debt / EBITDA

0.2x

FY 2024

EV / EBITDA

—

Employees

—